OsimertinibDrug resistance secondary to C797S mutation and pneumonitis : 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1740卷 / 1期

关键词：

D O I：

10.1007/s40278-019-58148-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：255 / 255

相关论文

共 50 条

[1] OsimertinibDrug resistance secondary to C797S mutation: case report
Reactions Weekly, 2018, 1728 (1) : 276 - 276
[2] OlmutinibAcquired C797S mutation leading to drug resistance: case report
Reactions Weekly, 2016, 1605 (1) : 140 - 140
[3] Brigatinib/cetuximab/osimertinibChemotherapy resistance secondary to C797S mutation in cis with T790M: case report
Reactions Weekly, 2019, 1753 (1) : 81 - 81
[4] Brigatinib/cetuximab/osimertinibChemotherapy resistance secondary to C797S mutation in cis with T790M: case report
Reactions Weekly, 2019, 1778 (1) : 99 - 99
[5] OsimertinibDrug resistance: 2 case reports
Reactions Weekly, 2021, 1867 (1) : 338 - 338
[6] C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?
Grabe, Tobias
Lategahn, Jonas
Rauh, Daniel
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (08): : 779 - 782
[7] OsimertinibDrug resistance: 3 case reports
Reactions Weekly, 2025, 2050 (1) : 465 - 465
[8] Dacomitinib/gefitinib/osimertinibDrug resistance: 2 case reports
Reactions Weekly, 2022, 1901 (1) : 192 - 192
[9] OsimertinibDrug resistance: 29 case reports
Reactions Weekly, 2019, 1737 (1) : 231 - 231
[10] OsimertinibDrug resistance: 7 case reports
Reactions Weekly, 2020, 1805 (1) : 228 - 228

← 1 2 3 4 5 →